ERIC AGUIAR
CIK 1262325 · last filed 2026-06-24
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.34M
Companies
6
Total Filings
48
Lifetime Open-Market Net
$57.25M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 10,579 | $85.55 | $905.0K | $0 | 8 | 2026-06-24 |
| BMEA | Director | — | $1.25 | — | $0 | 6 | 2026-06-12 |
| Invitae Corp (NVTA) Delisted | Director | 3,857,782 | $0.09 | $343.7K | -$2.32M | 15 | 2023-05-01 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Director | 24,575,501 | — | — | $55.01M | 5 | 2020-05-29 |
| BHVN | Director | 31,400 | $13.77 | $432.4K | -$3.10M | 13 | 2020-01-24 |
| Altimmune, Inc. (HAQ.WS) Delisted | 10%+ Owner | 250,000 | — | — | $7.66M | 1 | 2007-08-07 |
Recent Filings · Page 2 of 5
48 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-24 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2022-05-02 | Invitae Corp (NVTA) Delisted | Grant (A) | +43,400 | $0 | EDGAR |
| 2021-06-22 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2021-05-04 | Invitae Corp (NVTA) Delisted | Grant (A) | +11,500 | $0 | EDGAR |
| 2021-04-19 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2020-12-18 | Invitae Corp (NVTA) Delisted | Mixed | — | -$268.4K | EDGAR |
| 2020-11-18 | Invitae Corp (NVTA) Delisted | Mixed | — | -$1.11M | EDGAR |
| 2020-07-16 | Invitae Corp (NVTA) Delisted | Mixed | — | -$259.1K | EDGAR |
| 2020-06-04 | BBIO | Grant (A) | — | $0 | EDGAR |
| 2020-05-29 | Eidos Therapeutics, Inc. (EIDX) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.